Michael Leo

home / authors / michael-leo

Articles

38 Comparing Risk Stratification and Radiotherapy Benefit for Patients With DCIS Using a 7-Gene Biosignature as Compared to a Clinicopathologic Nomogram

38 Comparing Risk Stratification and Radiotherapy Benefit for Patients With DCIS Using a 7-Gene Biosignature as Compared to a Clinicopathologic Nomogram

Julie A. Margenthaler, MD;Karuna Mittal;Frank A. Vicini, MD;Chirag Shah, MD;Rachel Rabinovitch, MD;Pat W. Whitworth;Brian Czerniecki;David J. Dabbs;G. Bruce Mann;Fredrik Wärnberg;Sheila Weinmann;Michael Leo;Steven C. Shivers;Troy Bremer
April 26th 2023
39 7-Gene Predictive Biosignature Improves Risk Stratification for Breast Ductal Carcinoma In Situ Patients Compared to Clinicopathologic Criteria, Identifying a Low-Risk Group Not Clinically Benefiting from Adjuvant Radiotherapy

39 7-Gene Predictive Biosignature Improves Risk Stratification for Breast Ductal Carcinoma In Situ Patients Compared to Clinicopathologic Criteria, Identifying a Low-Risk Group Not Clinically Benefiting from Adjuvant Radiotherapy

Rachel Rabinovitch, MD;Frank A. Vicini, MD;Chirag Shah, MD;Julie A. Margenthaler, MD;Brian Czerniecki;Pat W. Whitworth;David J. Dabbs;G. Bruce Mann;Fredrik Wärnberg;Sheila Weinmann;Michael Leo;Jess Savala;Steven C. Shivers;Karuna Mittal;Troy Bremer
April 26th 2023
40 Characterization of Recurrence Risk After Lumpectomy and Radiotherapy in HER2-Positive Ductal Carcinoma in Situ of the Breast Using a 7-Gene Predictive Biosignature: Implications for the NSABP-B43 Trial Results

40 Characterization of Recurrence Risk After Lumpectomy and Radiotherapy in HER2-Positive Ductal Carcinoma in Situ of the Breast Using a 7-Gene Predictive Biosignature: Implications for the NSABP-B43 Trial Results

Frank A. Vicini, MD;Chirag Shah, MD;Rachel Rabinovitch, MD;Pat W. Whitworth;Julie A. Margenthaler, MD;Brian Czerniecki;David J. Dabbs;Sheila Weinmann;Michael Leo;G. Bruce Mann;Fredrik Wärnberg;Jess Savala;Steven C. Shivers;Karuna Mittal;Troy Bremer
April 26th 2023

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
A 78-Year-Old Woman With Nonpruritic Periorbital Purpura Around Her Eyelids
Published: August 13th 2011 | Updated: October 22nd 2024
A 78-Year-Old Woman With Nonpruritic Periorbital Purpura Around Her Eyelids
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: October 22nd 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Cancer rehabilitation medicine may help bridge a gap in oncology care, according to Jessica Cheng, MD.
Published: September 4th 2024 | Updated: October 22nd 2024
Cancer Rehabilitation Medicine: “Bridging the Gap” With Supportive Care